[ TaNeDS (Take a New Challenge for Drug diScovery) | Research funding ]
TaNeDS (Take a New Challenge for Drug diScovery) is Daiichi Sankyo's call for projects aiming at generating breakthrough pharmaceutical drugs for human health in one of Daiichi Sankyo's research interests: oncology, pain / neuroscience, cardiovascular and renal diseases, rare diseases, other diseases, cell therapy, technology and related research.
Who can apply: partnerships between scientists in Daiichi Sankyo and principal investigators affiliated with universities, research institutions and/or small biotech in the EU, Iceland, Norway, Switzerland, Israel and the United States.
Type of grants:
- Type A: for projects at target discovery stage or early stage of target/technology validation.
- Type B: for projects at an advanced stage.
- Type A: € (Europe) / $ (US) 50,000 – 75,000 per year, plus overhead
- Type B: € (Europe) / $ (US) 100,000 – 150,000 per year, plus overhead
Duration: 24 months
Deadline: 15 February 2019
Preliminary decision: mid-March 2019
Interview: mid-May 2019
Final decision: mid-June 2019
Start of the project: August/September 2019
Note: your application should contain only non-confidential information.
For further information, please have a look at the call webpage, FAQs and application form.